We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
(+23%)
Cap. Flow
-$8.07M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
18.2
quarters
Top 10 Avg Time Held
3.2
quarters
Top 20 Avg Time Held
7.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$43.3M |
| 2 |
Mine Safety
MSA
|
+$37.1M |
| 3 |
Yesway Inc
YSWY
|
+$34.7M |
| 4 |
Dorman Products
DORM
|
+$24.6M |
| 5 |
Avantor
AVTR
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cohu
COHU
|
+$54.5M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$51.1M |
| 3 |
MKS Inc
MKSI
|
+$44.5M |
| 4 |
Vishay Intertechnology
VSH
|
+$40.2M |
| 5 |
Littelfuse
LFUS
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.88% |
| 2 | Technology | 19.45% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 12.86% |
| 5 | Healthcare | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
726
BellRing Brands
BRBR
$999M
| $166K | ﹤0.01% |
+12,822
| New | +$155K |
2026 Q2
0 quarters
|
|
727
DELISTED
Cross Country Healthcare
CCRN
| $143K | ﹤0.01% |
10,790
-534,590
| -98% | -$6.33M |
2025 Q4
2 quarters
|
|
728
Angi Inc
ANGI
$257M
| $136K | ﹤0.01% |
22,867
+11,754
| +106% | +$72.5K |
2026 Q1
1 quarter
|
|
729
AMC Global Media
AMCX
$450M
| $124K | ﹤0.01% |
12,444
| – | – |
2023 Q2
12 quarters
|
|
730
Taboola.com
TBLA
$919M
| $123K | ﹤0.01% |
24,575
| – | – |
2025 Q1
5 quarters
|
|
731
GoodRx Holdings
GDRX
$1.19B
| $110K | ﹤0.01% |
38,114
| – | – |
2025 Q4
2 quarters
|
|
732
Teladoc Health
TDOC
$1.08B
| $109K | ﹤0.01% |
+12,912
| New | +$85.9K |
2026 Q2
0 quarters
|
|
733
Cricut
CRCT
$1.36B
| $106K | ﹤0.01% |
24,100
-355
| -1% | -$1.52K |
2024 Q1
9 quarters
|
|
734
Bumble
BMBL
$501M
| $105K | ﹤0.01% |
32,767
| – | – |
2026 Q1
1 quarter
|
|
735
Repay Holdings
RPAY
$317M
| $99.1K | ﹤0.01% |
23,587
| – | – |
2020 Q4
22 quarters
|
|
736
Coursera
COUR
$1.34B
| $97.5K | ﹤0.01% |
+17,289
| New | +$98.2K |
2026 Q2
0 quarters
|
|
737
BRC Group Holdings
RILY
$209M
| $93.4K | ﹤0.01% |
11,622
| – | – |
2026 Q1
1 quarter
|
|
738
Acco Brands
ACCO
$419M
| $89.5K | ﹤0.01% |
21,518
| – | – |
2024 Q3
7 quarters
|
|
739
Real REMAX Group Inc. Common Stock
REAX
$306M
| $82.3K | ﹤0.01% |
+4,520
| New | +$91.8K |
2026 Q2
0 quarters
|
|
740
Ironwood Pharmaceuticals
IRWD
$621M
| $78.1K | ﹤0.01% |
+18,553
| New | +$71.5K |
2026 Q2
0 quarters
|
|
741
Acacia Research
ACTG
$424M
| $68.1K | ﹤0.01% |
14,611
| – | – |
2025 Q4
2 quarters
|
|
742
Myriad Genetics
MYGN
$402M
| $67.1K | ﹤0.01% |
+11,748
| New | +$53.3K |
2026 Q2
0 quarters
|
|
743
Resources Connection
RGP
$97.5M
| $61.8K | ﹤0.01% |
14,550
| – | – |
2013 Q2
52 quarters
|
|
744
Marqeta
MQ
$1.9B
| $61K | ﹤0.01% |
3,756
| – | – |
2026 Q1
1 quarter
|
|
745
MiMedx Group
MDXG
$705M
| $56.7K | ﹤0.01% |
14,720
| – | – |
2026 Q1
1 quarter
|
|
746
Commerce.com Inc Series 1
CMRC
$289M
| $55.9K | ﹤0.01% |
+18,891
| New | +$54.1K |
2026 Q2
0 quarters
|
|
747
Niagen Bioscience
NAGE
$208M
| $38.8K | ﹤0.01% |
+12,169
| New | +$49.4K |
2026 Q2
0 quarters
|
|
748
ADMA Biologics
ADMA
$2.28B
| – | – |
-27,124
| Closed | -$244K | – |
|
749
Adient
ADNT
$1.33B
| – | – |
-30,099
| Closed | -$608K | – |
|
750
Addus HomeCare
ADUS
$2.16B
| – | – |
-6,048
| Closed | -$566K | – |
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
- Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
- Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
- Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
- Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
- Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
- Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.